Stockscreener 앱 받기
21.23
0.07%
-0.055
전일 마감가:
$21.18
열려 있는:
$21.41
하루 거래량:
160.14K
Relative Volume:
0.31
시가총액:
$998.88M
수익:
$723.55M
순이익/손실:
$157.72M
주가수익비율:
7.0783
EPS:
3
순현금흐름:
$170.15M
1주 성능:
-5.68%
1개월 성능:
-18.53%
6개월 성능:
-40.65%
1년 성능:
-46.61%
1일 변동 폭
$21.09
$21.65
1주일 범위
$21.09
$22.83
52주 변동 폭
$21.09
$53.95
Amphastar Pharmaceuticals Inc Stock (AMPH) Company Profile
명칭
Amphastar Pharmaceuticals Inc
전화
909-980-9484
주소
11570 SIXTH STREET, RANCHO CUCAMONGA, CA
AMPH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AMPH
Amphastar Pharmaceuticals Inc
|
21.19 | 1.07B | 723.55M | 157.72M | 170.15M | 3.00 |
|
ZTS
Zoetis Inc
|
151.83 | 70.25B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.70 | 47.44B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.725 | 45.15B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
15.91 | 19.07B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
297.72 | 13.28B | 2.99B | 1.21B | 1.13B | 25.06 |
Amphastar Pharmaceuticals Inc Stock (AMPH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-12 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2025-02-04 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2024-11-22 | 개시 | Wells Fargo | Equal Weight |
| 2024-03-05 | 개시 | JP Morgan | Overweight |
| 2023-11-17 | 개시 | BofA Securities | Neutral |
| 2023-07-25 | 재개 | Jefferies | Buy |
| 2022-10-21 | 재개 | Jefferies | Buy |
| 2022-07-29 | 개시 | CapitalOne | Overweight |
| 2022-01-07 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2021-01-08 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2020-10-05 | 업그레이드 | Northland Capital | Market Perform → Outperform |
| 2020-05-01 | 개시 | Northland Capital | Outperform |
| 2019-03-13 | 다운그레이드 | Needham | Buy → Hold |
| 2019-03-13 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
| 2018-08-10 | 재확인 | Needham | Buy |
| 2018-03-13 | 재확인 | Needham | Buy |
| 2017-12-01 | 재확인 | Needham | Buy |
| 2017-11-09 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2017-09-27 | 재확인 | Needham | Buy |
| 2017-03-14 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2016-08-09 | 재확인 | Needham | Buy |
| 2016-05-10 | 재확인 | Needham | Buy |
| 2016-02-19 | 개시 | Wells Fargo | Outperform |
| 2015-06-19 | 재확인 | Needham | Buy |
| 2015-06-03 | 개시 | Raymond James | Strong Buy |
| 2014-07-21 | 개시 | Needham | Buy |
모두보기
Amphastar Pharmaceuticals Inc 주식(AMPH)의 최신 뉴스
What makes Amphastar Pharmaceuticals Inc. stock price move sharplyFree Premium Stock Market Reports - Newser
Why Amphastar Pharmaceuticals Inc. stock attracts strong analyst attentionFree Professional Portfolio Management - Newser
Amphastar to Quadruple Domestic Manufacturing - Association for Accessible Medicines
How Amphastar Pharmaceuticals Inc. stock performs during market volatilityFree Stock Investment Discussion Area - Newser
Amphastar stock hits 52-week low at $21.47 amid challenging year - Investing.com Canada
Amphastar to quadruple production capacity at California headquarters By Investing.com - Investing.com Nigeria
Amphastar Pharmaceuticals Aims to Quadruple Domestic Manufacturing Capacity at Rancho Cucamonga Headquarters - ACCESS Newswire
Amphastar Plans Massive 4X Production Boost: Major US Pharma Manufacturing Expansion Coming by 2028 - Stock Titan
Amphastar Pharmaceuticals (NASDAQ:AMPH) Hits New 52-Week LowWhat's Next? - MarketBeat
When the Price of (AMPH) Talks, People Listen - news.stocktradersdaily.com
55,795 Shares in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Acquired by SteelPeak Wealth LLC - MarketBeat
Acadia Healthcare, 10x Genomics, Amphastar Pharmaceuticals, Myriad Genetics, and QuidelOrtho Stocks Trade Down, What You Need To Know - TradingView
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Purchased by Cambridge Investment Research Advisors Inc. - Defense World
Allspring Global Investments Holdings LLC Has $434,000 Stock Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Amphastar Pharmaceuticals (NASDAQ:AMPH) Sets New 12-Month LowHere's Why - MarketBeat
JPMorgan Downgrades Amphastar Pharmaceuticals (AMPH) to Neutral from Overweight, Brings PT Down to $30 - MSN
13 Cheap Healthcare Stocks with Huge Upside Potential - Insider Monkey
Floyd F. Petersen Sells 500 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Stock - MarketBeat
Illinois Municipal Retirement Fund Sells 604 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Amphastar Pharmaceuticals’s Q1 Earnings Call: Our Top 5 Analyst Questions - TradingView
(AMPH) On The My Stocks Page - news.stocktradersdaily.com
State of Alaska Department of Revenue Decreases Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Naloxone Market Is Booming So Rapidly 2025-2032 -Viatris Inc., - openPR.com
Amphastar Pharmaceuticals (AMPH): Buy, Sell, or Hold Post Q1 Earnings? - Yahoo Finance
Boston Trust Walden Corp Acquires 236,704 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
GAMMA Investing LLC Purchases 37,735 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Rhumbline Advisers Increases Stock Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
GAMMA Investing LLC Has $1.12 Million Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
CX Institutional Makes New Investment in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Bridge City Capital LLC Increases Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Where are the Opportunities in (AMPH) - news.stocktradersdaily.com
AMPH Q1 Earnings Call: Product Mix Shift and Margin Pressures Highlight Competitive Challenges - Yahoo Finance
Amphastar Pharmaceuticals, Inc.'s (NASDAQ:AMPH) Stock Is Going Strong: Is the Market Following Fundamentals? - simplywall.st
California State Teachers Retirement System Sells 595 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Trims Stock Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Director Sells $12,835.00 in Stock - MarketBeat
Wellington Management Group LLP Trims Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Short Interest in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Rises By 24.9% - MarketBeat
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $3.09 Million Stock Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Squarepoint Ops LLC Has $656,000 Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Amphastar Pharmaceuticals director sells $12,835 in stock - Investing.com Australia
Amphastar at Jefferies Conference: Strategic Focus on Growth - Investing.com Australia
Amphastar at Jefferies Conference: Strategic Focus on Growth By Investing.com - Investing.com Canada
Global Antidote Market to Cross the USD 4 Billion Mark by 2032 | DelveInsight - GlobeNewswire Inc.
Nuveen Asset Management LLC Sells 112,307 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Amphastar Pharmaceuticals director sells $12,835 in stock By Investing.com - Investing.com South Africa
Amphastar Pharmaceuticals Inc (AMPH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
6.71%
0.15%
자본화:
|
볼륨(24시간):